Viral Agents Causing Brown Cap Mushroom Disease of Agaricus bisporus

• Daniel Eastwood ^[1] ; Julian Green ^[2] ; Helen Grogan ^[3] ; Kerry Burton ^[4]
  1. [1] aSwansea University, Department of Biosciences, Swansea, United Kingdom
  2. [2] bUniversity of Warwick, Warwick HRI, Coventry, United Kingdom; cTeagasc, Ashtown Food Research Centre, Dublin, Ireland
  3. [3] cTeagasc, Ashtown Food Research Centre, Dublin, Ireland
  4. [4] dEast Malling Research, Kent, United Kingdom

  Mostrar afiliaciones +
• Localización: Applied and Environmental Microbiology, ISSN 0099-2240, Vol. 81, Nº 20, 2015, págs. 7125-7134
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • The symptoms of viral infections of fungi range from cryptic to severe, but there is little knowledge of the factors involved in this transition of fungal/viral interactions. Brown cap mushroom disease of the cultivated Agaricus bisporus is economically important and represents a model system to describe this transition. Differentially expressed transcript fragments between mushrooms showing the symptoms of brown cap mushroom disease and control white noninfected mushrooms have been identified and sequenced. Ten of these RNA fragments have been found to be upregulated over 1,000-fold between diseased and nondiseased tissue but are absent from the Agaricus bisporus genome sequence and hybridize to double-stranded RNAs extracted from diseased tissue. We hypothesize that these transcript fragments are viral and represent components of the disease-causing agent, a bipartite virus with similarities to the family Partitiviridae. The virus fragments were found at two distinct levels within infected mushrooms, at raised levels in infected, nonsymptomatic, white mushrooms and at much greater levels (3,500 to 87,000 times greater) in infected mushrooms exhibiting brown coloration. In addition, differential screening revealed 9 upregulated and 32 downregulated host Agaricus bisporus transcripts. Chromametric analysis was able to distinguish color differences between noninfected white mushrooms and white infected mushrooms at an early stage of mushroom growth. This method may be the basis for an “on-farm” disease detection assay.